answersLogoWhite

0

What is Doxorubicin?

Updated: 11/12/2022
User Avatar

Wiki User

10y ago

Best Answer

It's the Generic name for the Brand name Adriamycin, an intravenous cancer drug.

User Avatar

Wiki User

10y ago
This answer is:
User Avatar

Add your answer:

Earn +20 pts
Q: What is Doxorubicin?
Write your answer...
Submit
Still have questions?
magnify glass
imp
Related questions

How does doxorubicin affect DNA methylation?

Doxorubicin inhibits methylation of DNA.


Is doxorubicin is water soluble?

Doxorubicin has a solubility of 10mg in 1 ml of water, which should be warmed slightly.


What is the antidote for Doxorubicin?

hyaluronidase


What is the dosage form of doxorubicin?

Intravenous


With doxorubicin admistration it is essential that the nurse closely monitor for the patients?

yes


Drugs containing primary amine as afunctional group?

Doxorubicin, an anticancer drug.


What drug combinations are commonly used in treatment of small cell lung cancer?

cyclophosphamide (Cytoxan), doxorubicin (Adriamycin), and vincristine (Oncovin), or etoposide and cisplatin.


What has the author Heidi Traunecker written?

Heidi Traunecker has written: 'The biology of drug resistance in human sarcoma cells following a brief exposure to doxorubicin'


What drugs are used in chemotherapy for Hodgkin's disease?

MOPP (either mechlorethamine or methotrexate with Oncovin, procarbazine, prednisone) and ABVD (Adriamycin or doxorubicin, bleomycin, vincristine, dacarbazine).


What are the drug interactions associated with the use of rosemary?

Appears to increase the effects of doxorubicin, a cancer medication. Relatively few interactions between rosemary and Western pharmaceuticals have been reported.


What chemotherapeutic regime is sometimes recommended to treat MALT lymphoma?

At present, a chemotherapeutic regime designated CHOP includes the anti-cancer drugs cyclophosphamide, doxorubicin, vincristine, and prednisone.


What has the author Jamei R Eng written?

Jamei R. Eng has written: 'Pharmacogenomics of paclitaxel and doxorubicin resistance in human MCF-7 breast cancer cell lines'